JSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Jasper Therapeutics Inc (JSPR) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of positive financial performance, no significant news catalysts, and weak technical indicators suggest that this stock does not align with the investor's goals. Additionally, the stock's trend indicates a higher likelihood of short-term declines, making it unsuitable for immediate investment.
The MACD is slightly positive at 0.0206, indicating weak bullish momentum, but it is contracting. RSI at 51.4 is neutral, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision in price direction. Key support and resistance levels are close to the current price, with a pivot at 1.363, resistance at 1.432, and support at 1.294.
Hedge funds have significantly increased their buying activity by 364.54% over the last quarter, which could indicate institutional interest.
No recent news or event-driven catalysts. Insider trading activity is neutral. The stock trend analysis predicts a decline of -0.59% in the next day, -1.84% in the next week, and -3.61% in the next month. Additionally, there is no recent activity from politicians or influential figures, and the financial performance is weak.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income slightly improved to -18.736 million (up 0.53% YoY), but EPS dropped to -1.13 (down -8.87% YoY). Gross margin remains at 0, reflecting no profitability.
No recent analyst ratings or price target updates are available for JSPR.
